COMPARISON OF PLASMA PCR AND BRONCHOALVEOLAR LAVAGE FLUID CULTURE FOR DETECTION OF CYTOMEGALOVIRUS-INFECTION IN ADULT BONE-MARROW TRANSPLANT RECIPIENTS

被引:36
作者
ASPIN, MM
GALLEZHAWKINS, GM
GIUGNI, TD
TEGTMEIER, B
LANG, DJ
SCHMIDT, GM
FORMAN, SJ
ZAIA, JA
机构
[1] CITY HOPE NATL MED CTR, DEPT INFECT DIS, DIV PEDIAT, DUARTE, CA 91010 USA
[2] CHILDRENS HOSP ORANGE CTY, DEPT INFECT DIS, ORANGE, CA 92668 USA
[3] CITY HOPE NATL MED CTR, DEPT HEMATOL & BONE MARROW TRANSPLANTAT, DUARTE, CA 91010 USA
[4] CITY HOPE NATL MED CTR, DIV CLIN PATHOL, DUARTE, CA 91010 USA
关键词
D O I
10.1128/JCM.32.9.2266-2269.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Plasma PCR for human cytomegalovirus (CMV) DNA was compared with bronchoalveolar lavage (BAL) fluid culture as an indicator for disseminated CMV infection. Thirteen (32.5%) of 40 consecutive bone marrow transplant (BMT) recipients were BAL fluid culture positive for CMV on day 35 post-BMT, and 9 (69%) of the 13 had positive plasma PCRs between days 28 and 49. Of the 27 with negative BAL fluid cultures, 2 (7%) had positive plasma PCRs (P < 0.0001). Plasma CMV DNA in BMT recipients is a useful clinical marker for serious infection.
引用
收藏
页码:2266 / 2269
页数:4
相关论文
共 28 条
[1]   PROPHYLACTIC USE OF GANCICLOVIR IN ALLOGENEIC BONE-MARROW TRANSPLANTATION - ABSENCE OF CLINICAL CYTOMEGALOVIRUS-INFECTION [J].
ATKINSON, K ;
DOWNS, K ;
GOLENIA, M ;
BIGGS, J ;
MARSHALL, G ;
DODDS, A ;
CONCANNON, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (01) :57-62
[2]  
BOECKH M, 1992, BLOOD, V80, P1358
[3]   CYTOMEGALOVIRUS DNA DETECTION IN SERA FROM PATIENTS WITH ACTIVE CYTOMEGALOVIRUS INFECTIONS [J].
BRYTTING, M ;
XU, WM ;
WAHREN, B ;
SUNDQVIST, VA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) :1937-1941
[4]  
CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125
[5]   DETECTION OF CYTOMEGALO-VIRUS IN URINE FROM NEWBORNS BY USING POLYMERASE CHAIN-REACTION DNA AMPLIFICATION [J].
DEMMLER, GJ ;
BUFFONE, GJ ;
SCHIMBOR, CM ;
MAY, RA .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1177-1184
[6]  
EINSELE H, 1991, BLOOD, V77, P1104
[7]   POLYMERASE CHAIN-REACTION TO EVALUATE ANTIVIRAL THERAPY FOR CYTOMEGALOVIRUS DISEASE [J].
EINSELE, H ;
EHNINGER, G ;
STEIDLE, M ;
VALLBRACHT, A ;
MULLER, M ;
SCHMIDT, H ;
SAAL, JG ;
WALLER, HD ;
MULLER, CA .
LANCET, 1991, 338 (8776) :1170-1172
[8]   COMPARISON OF STANDARD TUBE AND SHELL VIAL CELL-CULTURE TECHNIQUES FOR THE DETECTION OF CYTOMEGALO-VIRUS IN CLINICAL SPECIMENS [J].
GLEAVES, CA ;
SMITH, TF ;
SHUSTER, EA ;
PEARSON, GR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (02) :217-221
[9]   GANCICLOVIR PROPHYLAXIS TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC MARROW TRANSPLANT [J].
GOODRICH, JM ;
BOWDEN, RA ;
FISHER, L ;
KELLER, C ;
SCHOCH, G ;
MEYERS, JD .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) :173-178
[10]   EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
MORI, M ;
GLEAVES, CA ;
DUMOND, C ;
CAYS, M ;
EBELING, DF ;
BUHLES, WC ;
DEARMOND, B ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1601-1607